PET/MRI machine learning model can eliminate sentinel lymph node biopsy in majority of breast cancer patients

World medicine December 17,2023

PET/MRI machine learning model can eliminate sentinel lymph node biopsy in majority of breast cancer patients

World medicine December 17,2023

PD-1 inhibitor treatment effective for localized mismatch repair-deficient colorectal cancer

by Elana GotkineFor localized mismatch repair-deficient (dMMR) colorectal cancer (CRC), neoadjuvant programmed death-1 (PD-1) inhibitor treatment is effective, according to a study published online Ja

World medicine December 17,2023

PD-1 inhibitor treatment effective for localized mismatch repair-deficient colorectal cancer

by Elana GotkineFor localized mismatch repair-deficient (dMMR) colorectal cancer (CRC), neoadjuvant programmed death-1 (PD-1) inhibitor treatment is effective, according to a study published online Ja

World medicine December 17,2023

PAD4 inhibition in neutrophils halts cancer progression and metastasis

byThe Wistar InstituteCancer Cell Dividing. Credit: The Wistar InstituteResearchers in the laboratory of Yulia Nefedova, M.D., Ph.D., at The Wistar Institute and collaborators at Jubilant Therap

Oncology December 17,2023

PAD4 inhibition in neutrophils halts cancer progression and metastasis

byThe Wistar InstituteCancer Cell Dividing. Credit: The Wistar InstituteResearchers in the laboratory of Yulia Nefedova, M.D., Ph.D., at The Wistar Institute and collaborators at Jubilant Therap

Oncology December 17,2023

New insights into colorectal cancer and E. coli

by Béatrice St-Cyr-Leroux,University of MontrealclbA and bft detection. a clbA and b bft presence in DNA extracted from fecal samples were detected using conventional qualitative PCR. M: marker;

Oncology December 17,2023

New insights into colorectal cancer and E. coli

by Béatrice St-Cyr-Leroux,University of MontrealclbA and bft detection. a clbA and b bft presence in DNA extracted from fecal samples were detected using conventional qualitative PCR. M: marker;

Oncology December 17,2023

Nectin-4 is widely expressed in head and neck squamous cell carcinoma

by Impact Journals LLCNectin-4 immunohistochemistry in HNSCC. Credit:Oncotarget(2022). DOI: 10.18632/oncotarget.28299Nectin-4 has been successfully established as a target molecule in loca

World medicine December 17,2023

Nectin-4 is widely expressed in head and neck squamous cell carcinoma

by Impact Journals LLCNectin-4 immunohistochemistry in HNSCC. Credit:Oncotarget(2022). DOI: 10.18632/oncotarget.28299Nectin-4 has been successfully established as a target molecule in loca

World medicine December 17,2023

Racial disparity in pro-metastatic tumor microenvironment among women with residual breast cancer after NAC

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainResidual tumors from Black patients with estrogen receptor (ER)-positive/HER2-negative primary breast cancer treated w

Oncology December 17,2023

Racial disparity in pro-metastatic tumor microenvironment among women with residual breast cancer after NAC

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainResidual tumors from Black patients with estrogen receptor (ER)-positive/HER2-negative primary breast cancer treated w

Oncology December 17,2023

Nab-paclitaxel does not extend biliary tract cancer survival, but may benefit some

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainAdding nab-paclitaxel to a standard treatment of gemcitabine plus cisplatin does not significantly extend median overall survival (OS) t

Oncology December 17,2023

Nab-paclitaxel does not extend biliary tract cancer survival, but may benefit some

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainAdding nab-paclitaxel to a standard treatment of gemcitabine plus cisplatin does not significantly extend median overall survival (OS) t

Oncology December 17,2023

MRI-guided radiotherapy produces fewer side effects, better quality of life for patients with localized prostate cancer

byUniversity of California, Los AngelesCredit: CC0 Public DomainFor men who undergo radiotherapy for localized prostate cancer, the precise targeting capabilities of MRI guidance resulted in few

World medicine December 17,2023

MRI-guided radiotherapy produces fewer side effects, better quality of life for patients with localized prostate cancer

byUniversity of California, Los AngelesCredit: CC0 Public DomainFor men who undergo radiotherapy for localized prostate cancer, the precise targeting capabilities of MRI guidance resulted in few

World medicine December 17,2023

Moderna's experimental cancer vaccine treats but doesn't prevent melanoma—a biochemist explains how it works

by Mark R. O'Brian,The ConversationCredit: Pixabay/CC0 Public DomainMediaoutletshave reported the encouraging findings of clinical trials for a new experimental vaccine developed

Oncology December 17,2023

Moderna's experimental cancer vaccine treats but doesn't prevent melanoma—a biochemist explains how it works

by Mark R. O'Brian,The ConversationCredit: Pixabay/CC0 Public DomainMediaoutletshave reported the encouraging findings of clinical trials for a new experimental vaccine developed

Oncology December 17,2023

MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway

by Impact Journals LLCEvaluation of the toxicity of MK256 in vivo. Credit:Oncotarget(2022). DOI: 10.18632/oncotarget.28305A new research paper titled "MK256 is a novel CDK8 inhibitor

Oncology December 17,2023

MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway

by Impact Journals LLCEvaluation of the toxicity of MK256 in vivo. Credit:Oncotarget(2022). DOI: 10.18632/oncotarget.28305A new research paper titled "MK256 is a novel CDK8 inhibitor

Oncology December 17,2023